Found: 14
Select item for more details and to access through your institution.
Sodium--glucose cotransporter-2 inhibitor combination therapy to optimize glycemic control and tolerability in patients with type 2 diabetes: focus on dapagliflozin-metformin.
- Published in:
- Diabetes, Metabolic Syndrome & Obesity: Targets & Therapy, 2016, v. 9, p. 71, doi. 10.2147/DMSO.S65588
- By:
- Publication type:
- Article
Bioequivalence among three methods of administering pantoprazole granules in healthy subjects.
- Published in:
- American Journal of Health-System Pharmacy, 2009, v. 66, n. 21, p. 1923, doi. 10.2146/ajhp080118
- By:
- Publication type:
- Article
Repeatability Characteristics of Simple Indices of Insulin Resistance: Implications for Research Applications.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2001, v. 86, n. 11, p. 5457, doi. 10.1210/jcem.86.11.7880
- By:
- Publication type:
- Article
Quantitative Insulin Sensitivity Check Index: A Simple, Accurate Method for Assessing Insulin Sensitivity In Humans.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2000, v. 85, n. 7, p. 2402, doi. 10.1210/jcem.85.7.6661
- By:
- Publication type:
- Article
24 hour ambulatory blood pressure monitoring during and following stroke
- Published in:
- 2005
- By:
- Publication type:
- Abstract
Quality measure attainment with dapagliflozin plus metformin extended-release as initial combination therapy in patients with type 2 diabetes: a post hoc pooled analysis of two clinical studies.
- Published in:
- Risk Management & Healthcare Policy, 2016, v. 9, p. 231, doi. 10.2147/RMHP.S108586
- By:
- Publication type:
- Article
Vitamin C pharmacokinetics: implications for oral and intravenous use.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Safety, Pharmacokinetics, and Pharmacodynamics of Single Doses of LXR-623, a Novel Liver X-Receptor Agonist, in Healthy Participants.
- Published in:
- Journal of Clinical Pharmacology, 2010, v. 50, n. 6, p. 643, doi. 10.1177/0091270009335768
- By:
- Publication type:
- Article
Safety, Pharmacokinetics, and Pharmacodynamics of Single Doses of LXR-623, a Novel Liver X-Receptor Agonist, in Healthy Participants.
- Published in:
- Journal of Clinical Pharmacology, 2009, v. 49, n. 6, p. 643, doi. 10.1177/0091270009335768
- By:
- Publication type:
- Article
Cystatin C- and Creatinine-Based Estimates of Glomerular Filtration Rate in Dapagliflozin Phase 3 Clinical Trials.
- Published in:
- Diabetes Therapy, 2016, v. 7, n. 1, p. 139, doi. 10.1007/s13300-016-0158-y
- By:
- Publication type:
- Article
Cardiovascular Outcome Studies With Novel Antidiabetes Agents: Scientific and Operational Considerations.
- Published in:
- Diabetes Care, 2013, v. 36, n. S2, p. S253, doi. 10.2337/dcS13-2041
- By:
- Publication type:
- Article
Ideal vitamin C intake.
- Published in:
- Biofactors, 2001, v. 15, n. 2-4, p. 71, doi. 10.1002/biof.5520150203
- By:
- Publication type:
- Article
Insights from cardiovascular outcome trials with novel antidiabetes agents: what have we learned? An industry perspective.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Intravenously administered vitamin C as cancer therapy: three cases.
- Published in:
- Canadian Medical Association Journal (CMAJ), 2006, v. 174, n. 7, p. 937, doi. 10.1503/cmaj.050346
- By:
- Publication type:
- Article